Eli Lilly Settles Zyprexa Lawsuit in Connecticut

Eli Lilly and Co. has agreed to pay the state $25.1 million to settle a lawsuit alleging that the drug company marketed its antipsychotic drug Zyprexa for unapproved uses and did not adequately reveal the drug's side effects for more than 10 years.

Connecticut State Attorney General Richard Blumenthal sued Eli Lilly last year, alleging that Lilly's efforts to promote the drug was harmful to consumers and cost state medical assistance programs more than $190 million to buy the drug and millions more to treat the injuries it caused.

The settlement, which is similar to recent agreements Lilly has already reached with two other states, requires the company to meet stricter standards for marketing in the future.



SEPT-30-09: Eli Lilly Settles Zyprexa Lawsuit with Connecticut [DRUG MAKER TO PAY STATE $25.1 MILLION TO SETTLE ZYPREXA LAWSUIT]

Legal Help

If you have a similar problem and would like to be contacted by a lawyer at no cost or obligation, please click the link below.
Published on Sep-30-09